Reading Between the Lines: Complete Blood Count-Derived Parameters as Prognostic Factors in Patients With Newly Diagnosed Acute Myeloid Leukemia [0.03%]
行间阅读：初诊急性髓系白血病患者中来自全血细胞计数的预后因素
Paulina Stefaniuk,Justyna Muzyka-Kasietczuk,Dorota Koczkodaj et al.
Paulina Stefaniuk et al.
Background: Research proved the prognostic significance of the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and red blood cell distribution width (RDW) in s...
Patterns of Different Cervical Cytokine Expression in High-Risk Human Papillomavirus-Infected Patients With Cervical Cancer and Its Precancerous Lesions [0.03%]
高危型人乳头瘤病毒感染的宫颈癌及其癌前病变患者细胞因子的不同模式表达研究
Shamoli Saha,Sharmin Sultana,Raad Rahmat et al.
Shamoli Saha et al.
Background: Cervical cancer is the second most common cancer in Bangladesh and is primarily caused by persistent high-risk human papillomavirus (HR-HPV) infection. Several risk factors, including immunological, genetic, e...
Retraction notice: "MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway" [0.03%]
撤稿声明："MicroRNA-19b 下调NR3C1 并通过PI3K/AKT/mTOR 途径增强结肠癌中的奥沙利铂耐药性"
[This retracts the article DOI: 10.1177/11795549211012666.]. © The Author(s) 2025.
Enfortumab Vedotin Plus Pembrolizumab Compared to Pembrolizumab and Standard Chemotherapy: Birds of a Feather Flock Together in Urothelial Cancer [0.03%]
恩福单抗联合派姆单抗与派姆单抗和标准化疗药的比较：膀胱癌中的同类物更相聚
Adriana Guarino,Matteo Santoni,Martina Catalano et al.
Adriana Guarino et al.
Concurrent Tumor-Treating Fields and Chemoradiotherapy: Outcomes in Grade 4 Glioma Patients [0.03%]
四级胶质瘤患者接受肿瘤治疗领域与化放疗联合治疗的疗效研究
Jintan Li,Jincheng Tao,Hongyu Lu et al.
Jintan Li et al.
Background: Surgical intervention, complemented by radiotherapy and chemotherapy with temozolomide, constitutes the conventional treatment protocol for patients with newly diagnosed grade 4 glioma. We have conducted a res...
Comparing Immunotherapy Versus Chemotherapy Alone as Second-Line Therapy for Malignant Tumors of the Biliary Tract: A Retrospective Study [0.03%]
免疫疗法与单独化疗作为胆道恶性肿瘤二线治疗的对比：一项回顾性研究
Chengzhi Jiang,Liu Yang,Ling Yang Kong et al.
Chengzhi Jiang et al.
Background: Bile duct carcinoma (BTC) is an uncommon malignant tumor of the gastrointestinal tract. Management is limited after the progress of first-line treatment. Immune checkpoint inhibitors (ICIs) have been proven po...
Modifiable Risk Factors Including Self-Perceived Stress for Breast Cancer in Hong Kong: A Case-Control Study of 10 757 Subject [0.03%]
香港乳腺癌病例对照研究：包括自我感知压力在内的10757例对象可改变危险因素分析
Winnie Yeo,Lok-Wa Yuen,Kelvin Kam-Fai Tsoi et al.
Winnie Yeo et al.
Background: In Hong Kong, breast cancer is the commonest female cancer. In addition to intrinsic risk factors that cannot be modified, other factors may be potentially modifiable. The objective of this report was to deter...
Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence [0.03%]
利用生成式人工智能进行转移性前列腺癌的适应性治疗
Youcef Derbal
Youcef Derbal
Despite the expanding therapeutic options available to cancer patients, therapeutic resistance, disease recurrence, and metastasis persist as hallmark challenges in the treatment of cancer. The rise to prominence of generative artificial in...
Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma [0.03%]
皮质醇瘤患者血浆纤维蛋白原的诊断及复发预测价值评估
Chengquan Ma,Bin Yang,Quanzong Mao
Chengquan Ma
Background: The correlation between fibrinogen levels and adrenocortical carcinoma (ACC) remains unclear. This study aimed to explore the value of preoperative plasma fibrinogen as a biomarker for ACC. ...
Serum Cystatin S (CST4): A Novel Prognostic Marker for Gastric Cancer [0.03%]
血清胱atin S(CST4)：胃癌的新型预后标志物
Chao Gu,Shan Chen,Lining Huang et al.
Chao Gu et al.
Background: Serum Cystatin S (CST4), a secretory protein that inhibits cellular matrix degradation, significantly influences the tumor microenvironment and tumor progression. However, the prognostic value of serum CST4 in...